The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weight loss and glucose ... tirzepatide, and new GLP-1 drugs in the research ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Dr. Archana Dhawan Bajaj explains the link between obesity and fertility, emphasizing the importance of a healthy weight for reproductive health. While weight-loss medications might aid in weight ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

Weight loss drugs catapulted many into a new wellness era, and gave hope to those with diabetes, obesity and who struggled to lose weight. The global anti-obesity drugs market — including the ...

Industry lobbyists maintain that this will reduce investment in new pill medications even if they may be the most effective and affordable option for patients. In addition to the weight-loss ...